(IN BRIEF) Research presented at ESC Congress 2025 has shown that GLP-1 receptor agonists, used to treat patients with heart failure and preserved ejection fraction, not only reduce hospitalizations and improve outcomes but also cut the environmental footprint of healthcare. … Read the full press release
Posted in Business, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Spain, Technology
Tagged carbon footprint of healthcare, environmental co-benefits, ESC Congress 2025, European Society of Cardiology, FLOW trial, GLP-1 receptor agonists, greenhouse gas emissions, healthcare sustainability, heart failure with preserved ejection fraction, HFpEF, Lahey Hospital & Medical Center, medical waste reduction, Sarju Ganatra, SELECT Trial, STEP HFpEF, Sustain Health Solutions, sustainability, Sustainable Healthcare
(IN BRIEF) Novo Nordisk, a global healthcare company, has reported the headline findings from the SELECT cardiovascular outcomes trial. This double-blinded study assessed the impact of subcutaneous once-weekly semaglutide 2.4 mg in comparison to placebo as an adjunct to standard … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Cardiovascular risk, Martin Holst Lange, Novo Nordisk, Obese Adults, overweight, SELECT Trial, Semaglutide 2.4 mg, Wegovy, wellness
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?